Skip to main content
. 2009 Nov 12;32(1):1–18. doi: 10.1159/000235758

Fig. 7.

Fig. 7

Dose-dependent malformation phenotypes caused by CB receptor agonists. Dose-dependent malformations caused by different doses of CB receptor agonists, anadamide (AEA), CP55940 (CP), and WIN55212-2 (WIN) given at the 2-cell stage show order of teratogenicity (CP > WIN > AEA) that fits their pharmacologic potency profiles in vertebrates [Breivogel and Childers, 2000; Prather et al., 2000; Palmer et al., 2002].

HHS Vulnerability Disclosure